TRANSIENT VANILLOID-LIKE RECEPTOR 2: NOVEL THERAPEUTIC TARGET AGAINST DRUG-RESISTANT LUNG CANCER

$156,000FY2018Department of the ArmyDOD

Ohio State University, The, Columbus OH

Investigators